Cybin Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
CYBN American 8731 https://www.cybin.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cybin Inc

Cybin Announces Approval of First-in-Human Dosing of its Proprietary DMT Molecule CYB004 - Feb 1st, 2023 12:30 pm
Cybin to Host Virtual R&D Day on February 28, 2023 - Jan 26th, 2023 12:30 pm
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Jan 24th, 2023 2:33 am
Cybin Announces Promising Results from Sponsored Kernel Flow® Feasibility Study Measuring Psychedelic Effects on the Brain - Jan 18th, 2023 12:30 pm
Trippy Trading: Top Psychedelic Stocks For 2023 - Jan 17th, 2023 10:00 am
Cybin Selects Generalized Anxiety Disorder as Target Indication for Deuterated DMT Molecule CYB004 - Jan 12th, 2023 12:30 pm
Cybin Outlines Upcoming Priorities and Milestones for its Clinical Development Programs - Jan 8th, 2023 10:00 pm
Cybin Highlights 2022 Accomplishments and Milestones - Dec 20th, 2022 1:00 pm
Cybin Presents CYB003 Preclinical Data at 2022 American College of Neuropsychopharmacology Annual Meeting - Dec 6th, 2022 9:01 pm
Cybin Inc. Presents CYB003 Preclinical Data at Neuroscience 2022 - Nov 15th, 2022 1:00 pm
Cybin Inc. Reports Second Quarter Financial Results and Recent Business Highlights - Nov 14th, 2022 10:01 pm
Cybin Provides Progress Update on its CYB004-E Phase 1 Trial - Nov 10th, 2022 1:00 pm
Cybin to Participate in the Jefferies London Healthcare Conference and Upcoming Investor Events - Nov 3rd, 2022 12:00 pm
Cybin Announces Scientific Presentation at the 5th Annual Neuropsychiatric & Psychedelics Drug Development Summit - Nov 1st, 2022 12:00 pm
Cybin’s EMBARK Program Announces Graduation of Facilitators - Oct 27th, 2022 12:00 pm
Cybin & The Chopra Foundation Recognize World Mental Health Day - Oct 10th, 2022 4:00 pm
Cybin Provides Update on its Intellectual Property Portfolio - Oct 6th, 2022 12:00 pm
Cybin Obtains Exclusive License to a Novel Catalog of Psychedelic-Based Compounds - Sep 27th, 2022 12:00 pm
Mindset Pharma Provides Strategic Intellectual Property License to Cybin - Sep 27th, 2022 11:30 am
Cybin to Participate in Upcoming Scientific and Investor Conferences - Sep 21st, 2022 12:00 pm